Class 2 Medicines Recall: Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml), EL(26)A/13

MHRA (UK)

OTHER

Published: 3/12/2026Detected: 3/22/2026

Initiates a Class 2 medicines recall for three batches of Curaleaf Oil due to identified low THC content, impacting product efficacy.

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

#medicines recall

#THC content

#product efficacy

#Curaleaf

#regulatory compliance

Access the original document directly from MHRA.

Free plan, 2-minute setup, no credit card required.

Not affiliated with the FDA, EMA, or Health Canada.